Latest filing published 19 Aug 2026 for TELA Bio, Inc., €7,175. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Heather C. Getz, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Butterfly Network, Inc., Myomo, Inc. and TELA Bio, Inc. Between 2 May 2022 and 17 August 2026, the trades on record add up to 20 filings.
On the open market, the record shows 4 purchases worth €73k and 7 sales worth €663k. On balance, insiders were net sellers of €591k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 9 share grants. So far in 2026, the count stands at 4 purchases and no sales.
A typical purchase (the median) is worth €11k. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 19 August 2026 came the latest disclosure, an open-market purchase for €7,175 in TELA Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations